Clinical Trials Browser

Phase 2 × Completed × Adalimumab × Clear all

NCT04009668 2024-10-30

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Phase 2 Completed

7 enrolled 12 charts

Macular dystrophy, corneal type 1, Glomerulosclerosis, Focal Segmental, Kidney Diseases, Nephrosis, Lipoid, Nephrotic Syndrome

NCT03180957 2024-06-28

RIDD

Phase 2 Completed

140 enrolled 29 charts

Dupuytren Contracture